Cargando…
A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease
INTRODUCTION: Volumetric image analysis to detect progressive brain tissue loss in patients with multiple sclerosis (MS) has recently been suggested as a promising marker for “no evidence of disease activity.” Software packages for longitudinal whole-brain volume analysis in individual patients are...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787548/ https://www.ncbi.nlm.nih.gov/pubmed/29416523 http://dx.doi.org/10.3389/fneur.2017.00727 |
_version_ | 1783295954479218688 |
---|---|
author | Rummel, Christian Aschwanden, Fabian McKinley, Richard Wagner, Franca Salmen, Anke Chan, Andrew Wiest, Roland |
author_facet | Rummel, Christian Aschwanden, Fabian McKinley, Richard Wagner, Franca Salmen, Anke Chan, Andrew Wiest, Roland |
author_sort | Rummel, Christian |
collection | PubMed |
description | INTRODUCTION: Volumetric image analysis to detect progressive brain tissue loss in patients with multiple sclerosis (MS) has recently been suggested as a promising marker for “no evidence of disease activity.” Software packages for longitudinal whole-brain volume analysis in individual patients are already in clinical use; however, most of these methods have omitted region-based analysis. Here, we suggest a fully automatic analysis pipeline based on the free software packages FSL and FreeSurfer. MATERIALS AND METHODS: Fifty-five T1-weighted magnetic resonance imaging (MRI) datasets of five patients with confirmed relapsing–remitting MS and mild to moderate disability were longitudinally analyzed compared to a morphometric reference database of 323 healthy controls (HCs). After lesion filling, the volumes of brain segmentations and morphometric parameters of cortical parcellations were automatically screened for global and regional abnormalities. Error margins and artifact probabilities of regional morphometric parameters were estimated. Linear models were fitted to the series of follow-up MRIs and checked for consistency with cross-sectional aging in HCs. RESULTS: As compared to leave-one-out cross-validation in a subset of the control dataset, anomaly detection rates were highly elevated in MRIs of two patients. We detected progressive volume changes that were stronger than expected compared to normal aging in 4/5 patients. In individual patients, we also identified stronger than expected regional decreases of subcortical gray matter, of cortical thickness, and areas of reducing gray–white contrast over time. CONCLUSION: Statistical comparison with a large normative database may provide complementary and rater independent quantitative information about regional morphological changes related to disease progression or drug-related disease modification in individual patients. Regional volume loss may also be detected in clinically stable patients. |
format | Online Article Text |
id | pubmed-5787548 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-57875482018-02-07 A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease Rummel, Christian Aschwanden, Fabian McKinley, Richard Wagner, Franca Salmen, Anke Chan, Andrew Wiest, Roland Front Neurol Neuroscience INTRODUCTION: Volumetric image analysis to detect progressive brain tissue loss in patients with multiple sclerosis (MS) has recently been suggested as a promising marker for “no evidence of disease activity.” Software packages for longitudinal whole-brain volume analysis in individual patients are already in clinical use; however, most of these methods have omitted region-based analysis. Here, we suggest a fully automatic analysis pipeline based on the free software packages FSL and FreeSurfer. MATERIALS AND METHODS: Fifty-five T1-weighted magnetic resonance imaging (MRI) datasets of five patients with confirmed relapsing–remitting MS and mild to moderate disability were longitudinally analyzed compared to a morphometric reference database of 323 healthy controls (HCs). After lesion filling, the volumes of brain segmentations and morphometric parameters of cortical parcellations were automatically screened for global and regional abnormalities. Error margins and artifact probabilities of regional morphometric parameters were estimated. Linear models were fitted to the series of follow-up MRIs and checked for consistency with cross-sectional aging in HCs. RESULTS: As compared to leave-one-out cross-validation in a subset of the control dataset, anomaly detection rates were highly elevated in MRIs of two patients. We detected progressive volume changes that were stronger than expected compared to normal aging in 4/5 patients. In individual patients, we also identified stronger than expected regional decreases of subcortical gray matter, of cortical thickness, and areas of reducing gray–white contrast over time. CONCLUSION: Statistical comparison with a large normative database may provide complementary and rater independent quantitative information about regional morphological changes related to disease progression or drug-related disease modification in individual patients. Regional volume loss may also be detected in clinically stable patients. Frontiers Media S.A. 2018-01-24 /pmc/articles/PMC5787548/ /pubmed/29416523 http://dx.doi.org/10.3389/fneur.2017.00727 Text en Copyright © 2018 Rummel, Aschwanden, McKinley, Wagner, Salmen, Chan and Wiest. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Neuroscience Rummel, Christian Aschwanden, Fabian McKinley, Richard Wagner, Franca Salmen, Anke Chan, Andrew Wiest, Roland A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease |
title | A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease |
title_full | A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease |
title_fullStr | A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease |
title_full_unstemmed | A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease |
title_short | A Fully Automated Pipeline for Normative Atrophy in Patients with Neurodegenerative Disease |
title_sort | fully automated pipeline for normative atrophy in patients with neurodegenerative disease |
topic | Neuroscience |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5787548/ https://www.ncbi.nlm.nih.gov/pubmed/29416523 http://dx.doi.org/10.3389/fneur.2017.00727 |
work_keys_str_mv | AT rummelchristian afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT aschwandenfabian afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT mckinleyrichard afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT wagnerfranca afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT salmenanke afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT chanandrew afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT wiestroland afullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT rummelchristian fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT aschwandenfabian fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT mckinleyrichard fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT wagnerfranca fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT salmenanke fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT chanandrew fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease AT wiestroland fullyautomatedpipelinefornormativeatrophyinpatientswithneurodegenerativedisease |